A carregar...

Effectiveness of addition of sirolimus to cyclosporine and mycophenolate mofetil-based graft-versus-host disease prophylaxis after unrelated nonmyeloablative hematopoietic cell transplantation: A multicentre phase III randomized trial

BACKGROUND: Acute graft-versus-host-disease (aGVHD) after nonmyeloablative human leukocyte antigen (HLA)-matched unrelated donor allogeneic hematopoietic cell transplantation (HCT) is associated with considerable morbidity and mortality. The trial evaluated the efficacy of adding sirolimus to cyclos...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet Haematol
Main Authors: Sandmaier, Brenda M., Kornblit, Brian, Storer, Barry E., Olesen, Gitte, Maris, Michael B., Langston, Amelia A., Gutman, Jonathan A., Petersen, Soeren L., Chauncey, Thomas R., Bethge, Wolfgang A., Pulsipher, Michael A., Woolfrey, Ann E., Mielcarek, Marco, Martin, Paul J., Appelbaum, Fred R., Flowers, Mary E.D., Maloney, David G., Storb, Rainer
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6686903/
https://ncbi.nlm.nih.gov/pubmed/31248843
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2352-3026(19)30088-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!